Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
Klaus Vedfelt/DigitalVision via Getty Images This week the Associated Press reported that the US Drug Enforcement Administration will reschedule cannabis from a Schedule 1 drug to Schedule 3. Without exaggeration, this is the most important development in the US for cannabis in recorded history. Investors recognized the importance of the reports, and many cannabis stocks…